VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical pharmacokinetics of the BCR-ABL tyrosine kinase inhibitor nilotinib.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical pharmacokinetics of the BCR-ABL tyrosine kinase inhibitor nilotinib.
Clinical pharmacokinetics of the BCR-ABL tyrosine kinase inhibitor nilotinib. Clin Pharmacol Ther. 2010 Feb; 87(2):197-203.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Antineoplastic Agents
Area Under Curve
Dietary Fats
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Food-Drug Interactions
Fusion Proteins, bcr-abl
Humans
Leukocyte Count
Male
Middle Aged
Protein-Tyrosine Kinases
Pyrimidines
Solubility
Young Adult
authors with profiles
HAGOP M KANTARJIAN